Objective: To characterize the brain-infiltrating immune cell repertoire in Rasmussen encephalitis (RE) with special focus on the subsets, clonality, and their cytokine profile.
which have in part shown promising results. [12] [13] [14] [15] [16] Given that the most effective treatment remains hemispherectomy/hemispherotomy with a significant risk of functional deterioration, there is a great need for better treatment options directed against pathophysiologic aspects and/ or a potential cause of the disease. 4 In this direction, we here studied the types of immune cells infiltrating the brain in RE using histopathology and ex vivo characterization of isolated cells by flow cytometry. We further investigated the presence of T-cell clonal (TCC) expansions, generated and characterized for the first time the most frequent TCCs from the brain of a patient with RE, and assessed their functional phenotype.
METHODS Patients. Case 1. A 4-year-old boy developed progressive focal neurologic deficits and seizures. He was diagnosed with bilateral RE based on the clinical symptoms, radiologic findings (figure 1), and histopathologic analysis from brain biopsies derived from both hemispheres. Cerebrospinal fluid (CSF) studies revealed normal glucose and albumin quotient, normal immunoglobulin G (IgG) index, no oligoclonal bands and was negative for neurotropic viruses. The CSF was also tested 10 months later and was normal except for the presence of oligoclonal bands. The boy underwent left vertical parasagittal hemispherotomy 1 and a half year later. Part of the resected brain tissue was obtained for research analyses. Serum was tested and was negative for paraneoplastic antibodies, namely antibodies against NMDA receptor, AMPA, GABA (B), mGluR1, mGluR5, LGI1, and Caspr2. The CSF was also tested and was negative for antibodies against Hu, Ri, Yo, amphiphysin, CV2 (CRMP5), Ta/ Ma2, Ma1, SOX1 and GAD, LGI1, Caspr2, and NMDA receptor (for further details, see online case description, appendix e-1, http://links.lww.com/NXI/A11).
Case 2. A 36-year-old man underwent MRI showing findings consistent with RE: hyperintense signal in the left cortical and subcortical area with cortical atrophy and enlargement of the lateral ventricle. A brain biopsy was consistent with RE and included in the study.
Case 3. A female patient with RE underwent a partial resection of the right hemisphere at the age of 7 to treat status epilepticus. Because of drug-resistant epileptic activity, the patient underwent functional hemispherotomy at the age of 25. The brain biopsy of the latter operation was included in this study and was consistent with RE. The brain biopsy from the first operation was not available.
Standard protocol approvals, registrations, and patient consents. The project was approved by the Cantonal Ethics Committee Zurich (no. , informed consent was obtained accordingly from the parents of the 4-year-old boy, and approval was received for the retrospective analyses of cases 2 and 3.
Immunohistochemistry. Formalin-fixed, paraffin-embedded brain tissue sections of diagnostic brain biopsies (5-mm thickness) were stained on a Leica Bond III-automated immunostaining platform (Leica Biosystems) with the appropriate antibodies (table e-1, http://links.lww.com/NXI/A9) in 1% bovine serum albumin. Tissue sections were analyzed using a Nikon Eclipse 80i light microscope equipped with an Olympus UC30 camera.
Isolation of brain-infiltrating mononuclear cells. This and all subsequent methods were performed from CNS tissue that was obtained and processed immediately after surgery from RE case 1. The brain biopsy was cut into small pieces and incubated with media containing 1 mg/mL collagenase A (Roche, Basel, Switzerland) and 0.1 mg/mL DNAse I (Roche) at 37°C for 60 minutes. Brain-infiltrating cells were isolated by Percoll density gradient centrifugation (GE Healthcare, Buckinghamshire, United Kingdom). The cells were characterized directly by flow cytometry, expanded with phytohemagglutinin (PHA)-L (SigmaAldrich, St. Louis, MO), or cryopreserved until further use.
Flow cytometry. For the direct phenotypic analysis of the mononuclear brain infiltrate, Fc-binding blocking with human IgG and staining with Live/Dead Aqua (Invitrogen, Waltham, MA) was performed, followed by staining with the appropriate antibodies (table e-1, http://links.lww.com/NXI/A9). Measurements were performed on an LSR II flow cytometer (BD, Franklin Lakes, NJ), and data were analyzed with FlowJo (Ashland, OR). High-throughput T-cell receptor sequencing. DNA was isolated using the AllPrep DNA/RNA Mini Kit (Qiagen, Limburg, Netherlands), and high-throughput sequencing for Vb T-cell receptor (TCR) was performed at Adaptive Biotechnologies (Seattle, WA) using the immunoSEQ platform. [17] [18] [19] Expansion of brain-infiltrating mononuclear cells and generation of TCCs. Brain-infiltrating mononuclear cells were expanded as bulk populations by seeding into 96-well plates 2,000 cells/well together with 1.5 3 10 5 allogeneic irradiated (3,000 radians) peripheral blood mononuclear cells, 1 mg/mL of PHA and human interleukin-2 (IL-2; supernatant kindly provided by Federica Sallusto, PhD, Bellinzona, Switzerland) in IMDM medium supplemented with 2 mM L-glutamine, 100 U/mL penicillin/streptomycin, 50 mg/mL gentamicin, and 5% human serum. IL-2 was added every 3-4 days, and at day 14, cells were pooled and cryopreserved. TCCs were generated by fluorescence activated cell sorting (FACS) (FACSAria III; BD) of specific Tcell populations stained with anti-CD4, anti-CD8, and appropriate anti-TCR Vb antibodies (Beckman Coulter, Brea, CA) and subsequently cloned by limiting dilution (0.3 cells/well) in 96-well plates. TCCs were then expanded using the above-described protocol and rechecked for purity by sequencing of the specific TCR Vb chain (Microsynth, Balgach, Switzerland) and flow cytometry.
Cytokine expression profiling of expanded braininfiltrating T cells. Brain-infiltrating mononuclear cells were analyzed for cytokine profiling after 1 expansion using intracellular cytokine staining on stimulation with 50 ng/mL phorbol myristate acetate (PMA; Sigma-Aldrich) and 1 mg/mL ionomycin (Sigma-Aldrich) in the presence of GolgiPlug (BD). After 5 hours, T cells were stained with Live/Dead Aqua, fixed and permeabilized with the Cytofix/Cytoperm Kit (BD), and stained with the appropriate antibodies (table e-1, http://links.lww.com/ NXI/A9). Unstimulated cells served as controls. Measurements were performed on an LSRFortessa flow cytometer (BD), and data were analyzed with FlowJo.
Cytokine expression profiling of TCCs. TCCs were stimulated with PMA and anti-CD3 (OKT3 antibody; Janssen-Ortho, Toronto, Canada) for 24 hours. Cytokine secretion of individual TCCs was measured in supernatants using a Th1/Th2/Th17 Cytokine Multi-Analyte ELISArray Kit (Qiagen) and a granzyme B ELISA kit (Mabtech, Nacka Strand, Sweden). Data were analyzed using GraphPad Prism (La Jolla, CA).
RESULTS

All 3 subtypes, CD4
1 , CD8
1
, and gd, are forming the T-cell infiltrate in RE. We first performed immunohistochemical analyses to investigate the similarities between the 3 RE cases. All 3 cases displayed prominent astrogliosis, strong microglial activation, T-cell infiltrates, and essential absence of B cells ( figure 2A ). Further characterization of the Tcell infiltrate confirmed the presence of CD8 1 T cells, some of them in direct contact to neurons in accordance with what has been described before. 8 The histopathologic findings were thus consistent with RE in all 3 cases. We observed also in all 3 cases the presence of CD4 1 T cells both in the perivascular compartment and in the parenchyma as well as infiltrating gd T cells (figure 2B). Apart from the T-cell staining, the gd-TCR antibody also displayed a regional staining of glial cells (data not shown).
To confirm these histopathologic findings and quantitatively assess and perform a more detailed analysis of the brain-infiltrating cells, we used brain tissue resected at hemispherotomy surgery from case 1. Figure 3A shows the methodological strategy of dissecting the tissue into 4 segments (seg1-seg4) for the various analyses.
Flow cytometric analysis of leukocytes (CD45 red and blue, respectively ( figure 3D and figure e-1, http://links.lww.com/NXI/A8). Five of the 13 most frequent TCCs in seg2 were not present in the CD4 1 or CD8 1 compartment of the expanded pools from seg4 (shown in black). The 2 most frequent TCCs in seg2 representing 15.56% and 13. 04% of the T-cell infiltrate were both CD8
1 . The third most expanded TCC in seg2 representing 6. 81% of the T-cell infiltrate was a CD4
1 TCC. The overall TCC match between seg2 and seg4 was 14. 5% for CD4 1 and 38.8% for CD8 1 TCCs, while 46.7% of the infiltrating T cells in seg2 were not present in seg4. We thus found that both CD4
1 and CD8
1 T-cell brain infiltrates are clonally expanded in RE case 1. 1 T-cell pool ( figure 4, A and B) . Of interest, 2 of the CD4
1 TCCs were also present in seg2. Based on our previous studies, a bias as a consequence of 1 round of PHA expansion is unlikely. 20 We therefore assume that partially overlapping T-cell repertoires shape the infiltrate in physically separate areas of the brain in this RE case. A search using the BLASTP program of the nonredundant protein database (blast. ncbi.nlm.nih.gov) indicated that none of the TCR sequences found in seg2 and seg4 matched any published sequence in the database. We examined the functional phenotype of the 6 brain-infiltrating TCCs by analyzing their cytokine profile ( figure 4B ). Among the CD4 1 TCCs, 2 TCCs (TCC3 and TCC16) displayed a Th1 phenotype releasing mainly Th1 cytokines, 2 TCCs (TCC14 and TCC15) had a Th1/2 multifunctional phenotype, and TCC18 released mainly Th2 cytokines. The only CD8
1 TCC analyzed (TCC23) released both Th1 and Th2 cytokines and hence exhibited also a multifunctional phenotype ( figure 4B ). Both the CD4
1 TCCs and the CD8 1 TCC produced granzyme B on stimulation (figure 4C). We thus observed both Th1 and Th1/2 multifunctional cytotoxic phenotypes of the individual TCCs.
DISCUSSION In this study, we report that besides CD8
1 T cells, both ab CD4 1 TCC and gd T cells infiltrate the brain in RE. Further analyses using FACS of CD4 1 and CD8 1 T cells and TCR Vbchain high-throughput sequencing from 2 different segments of brain tissue identified that not only the brain-infiltrating CD8
1 but also the CD4 1 T cells are clonally expanded. Prior evidence has shown that T cell-mediated inflammation in RE is dominated by CD8
1 TCCs, while an involvement of CD4 1 TCCs has not been considered. 7, 11, 21 In a seminal previous study, the investigators matched the TCR Vb between blood and brain T cells in 5 patients and found only CD8
1 T cells to be present in the RE brain. 7 For this reason, our finding that a large fraction of the TCCs that were present in both brain segments, and in particular the third and sixth most frequent TCCs, were CD4 1 , is surprising. The reason for the discrepancy between the previous study and ours is unclear but could be explained by methodological differences. Although, the previous study included more patients, identification of brain TCCs as being CD4 1 or CD8 1 T cells was performed by matching them to peripheral blood CD4 1 or CD8 TCCs. On the other hand, the setup and methods used in our study with direct sorting and sequencing from 2 different segments of the brain lesion allowed phenotyping the T-cell subpopulations directly from the brain. In support of our findings, histopathologic studies have also reported the presence of CD4
T cells in the RE brain. [22] [23] [24] [25] Our study, which documents not only the presence but also clonal expansion of CD4 1 T cells, indicates that CD4
T cells are likely involved in the disease process of RE and driven by a specific antigen. Given that this finding is derived from a bilateral RE case, further studies are needed to investigate whether this is also true for more typical RE cases in which only 1 hemisphere is affected. In addition to the oligoclonal expansion of CD4 1 and CD8 1 T cells, the presence of gd T cells suggests further complexity of the immunopathogenesis. We found that a major fraction (one-third) of the braininfiltrating gd T cells belong to the non-Vd2 1 subtype. Because blood gd T cells are mainly Vd2 1 , our finding indicates a specific infiltration rather than bystander recruitment into the brain. Almost half of the gd T cells were positive for CD8, which suggests that prior histopathologic assessments of RE tissue with anti-CD8 antibodies might have overestimated the contribution of CD8 1 ab T cells because at least a significant proportion of the CD8 1 T cells belong to the gd T-cell compartment. gd T cells constitute 1%-5% of total blood lymphocytes and approximately 50% of the lymphocytes in skin and mucosal tissues. They mediate defense mechanisms against bacteria, viruses, and protozoa and play a role in cancer, wound healing, and autoimmune diseases. 26 Regarding CNS autoimmunity, previous studies have shown that gd T cells are present in MS lesions, are oligoclonally expanded, and probably can react against heat-shock proteins. [27] [28] [29] It is important that a recent study has also reported the presence of gd (CD4 2 CD8 2 Vd1
) T cells with a restricted T-cell repertoire in RE. 30 Thus, because gd T cells are implicated in RE and both in viral/infectious and autoimmune diseases of the CNS, they should be included in future efforts to uncover the etiology of the disease.
A previous study comparing brain tissue from patients with RE and cortical dysplasia analyzed the cytokine profile in RE using reverse transcription PCR and showed evidence for a Th1/Tc1 response. 24 We here report the cytokine profile of the most frequent, CNSinfiltrating T-cell populations and individual TCCs in the brain. Individual CD4
1 TCCs displayed a Th1 phenotype with IFN-g and TNF secretion or a more complex multifunctional phenotype with additional secretion of IL-5 and IL-13. When investigating all 3 subpopulations of brain-infiltrating cells, namely CD4
1 , CD8 1 , and gd T cells, the majority of the cells expressed IFN-g and TNF but not IL-17.
In its most common form, RE affects only 1 hemisphere, but rare cases exist, in which the disease starts at earlier age, is more severe, and affects both hemispheres. 31 In case 1 with bilateral hemispheric involvement, the clinical course of the disease, involving the typical RE prodromal period, the intractable focal seizures followed by the acute stage until surgery, the MRI findings and evolution, the absence of antibodies involved in autoimmune encephalopathies, the histopathology being in accordance with the Bien diagnostic criteria and compatible with what usually is seen in typical unilateral RE cases, as evaluated by 2 independent neuropathologists, the classic finding of T cells being in contact to neurons, and, finally, the response to surgical treatment strongly support that this is one of the very rare cases of bilateral RE. 32 The presence of brain-infiltrating gd T cells in all 3 cases also strongly suggests that bilateral and unilateral cases have a similar pathogenesis.
Taken together, our data fit well with previous knowledge and provide new T cells may also act as cytotoxic effectors, i.e., by the above-mentioned IFN-g-mediated elimination of synapses, by inducing glial apoptosis and by enhancing tissue damage via granzyme B. [33] [34] [35] [36] Finally, the identification of brain-infiltrating gd T cells as part of the inflammatory process in RE implicates a third T-cell subtype. Overall, we find that the T-cell infiltrate in RE is considerably more complex than previously thought. While our data do not allow to discern which of the T-cell subtypes initiates the inflammatory process, their common cytokine patterns indicate that they jointly participate in the pathogenesis of RE. It will be important now to identify the target antigens of both CD4
1 and CD8 1 TCCs and clarify if these are self-or foreign antigens and if molecular mimicry is involved. Future studies about the possible antigens causing or driving the disease should investigate all 3 T-cell populations, CD8
1 and CD4 1 TCCs, and gd T cells. To this end, we have expanded for the first time the most prominent CD4 1 and CD8 1 TCCs, which can be used as important tools in unbiased approaches to identify possible antigens involved in the etiology and/or pathogenesis of RE.
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